Contact Us

Guidant Defibrillators
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Which Guidant cardiac defibrillator was implanted?








If other, what is the name of the defibrillator that was implanted?

Date the device was implanted:

Is the device still implanted?

What medical condition prompted the use of the device?

Please describe any problems or injuries caused by the product:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Guidant cautions doctors to check some defibrillators

Mar 13, 2006 | AP

Guidant Corp., which is being acquired for $27 billion by Boston Scientific Corp., cautioned doctors Monday to check the voltage on certain implantable defibrillators after the company received several reports of defective devices.

The Indianapolis-based medical device maker issued the warning for its Contak Renewal 3 RF and Contak Renewal 4 RF models of defibrillators, which are devices that shock the heart back to a normal rhythm.

Guidant said it had received 39 reports from doctors saying defibrillators that had been tested before being implanted had a lower-than-expected battery voltage. None of the 39 devices were put into patients.

The voltage decline is related to a sustained, low level current that can only occur during storage and shipment before implantation. The company said about 4,000 Contak Renewal 3 RF and Contak Renewal 4 RF models have already been implanted, but it has not received any reports of this particular voltage problem.

Guidant said that the Food and Drug Administration may classify the notification to doctors as a product recall.

The company reminded doctors to check their inventory for the defect and to always perform the voltage check before implanting the device.

The notification follows a long line of product woes for Guidant that started in the summer when the company recalled thousands of pacemakers and defibrillators for a variety of reasons.


Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo